Oxidative stress in traumatic brain injury

Current Medicinal Chemistry

Volumn 21, Issue 10, 2014, Pages 1201-1211

  Rodríguez Rodríguez, Ana ^a   Egea Guerrero, Juan José ^a   Murillo Cabezas, Francisco ^a   Carrillo Vico, Antonio ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Instituto de Biomedicina de Sevilla   (Spain)

Author keywords

Brain damage; Cerebral ischemia; Oxidative stress biomarker; Reactive oxygen species; Traumatic brain injury

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; CATALASE; DEXANABINOL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDE; MELATONIN; NIMODIPINE; NITRIC OXIDE SYNTHASE; PROGESTERONE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TIRILAZAD; URIC ACID; XANTHINE OXIDASE;

AEROBIC METABOLISM; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; CLINICAL TRIAL (TOPIC); DRUG TREATMENT FAILURE; ENZYME ACTIVATION; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; OXYGEN SUPPLY; PATHOGENESIS; PROTEIN CARBONYLATION; TRAUMATIC BRAIN INJURY;

ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN INJURIES; CATALASE; CLINICAL TRIALS AS TOPIC; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84896266772     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666131217153310     Document Type: Article

References (116)

1. Leon-Carrion, J.; Dominguez-Morales Mdel, R.; Barroso y Martin, J. M.; Murillo-Cabezas, F. Epidemiology of traumatic brain injury and subarachnoid hemorrhage. Pituitary, 2005, 8(3-4), 197-202.
2. Hyder, A. A.; Wunderlich, C. A.; Puvanachandra, P.; Gururaj, G.; Kobusingye, O. C. The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation, 2007, 22(5), 341-353.
3. Tagliaferri, F.; Compagnone, C.; Korsic, M.; Servadei, F.; Kraus, J. A systematic review of brain injury epidemiology in Europe. Acta Neurochir. (Wien.), 2006, 148(3), 255-268; discussion 268.
4. Finfer, S. R.; Cohen, J. Severe traumatic brain injury. Resuscitation, 2001, 48(1), 77-90. (Pubitemid 32121667)
5. Munoz-Cespedes, J. M.; Paul Laprediza, N. M.; Pelegrin-Valero, C.; Tirapu-Ustarroz, J. Prognostic factors in head injuries. Rev. Neurol., 2001, 32(4), 351-364. (Pubitemid 32521075)
6. Bramlett, H. M.; Dietrich, W. D. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab., 2004, 24(2), 133-150. (Pubitemid 38199107)
7. Stelmasiak, Z.; Dudkowska-Konopa, A.; Rejdak, K. Head trauma and neuroprotection. Med. Sci. Monit., 2000, 6(2), 426-432. (Pubitemid 30313189)
8. Revuelto-Rey, J.; Egea-Guerrero, J. J.; Munoz-Sanchez, M. A.; Murillo-Cabezas, F. Cerebral microdialysis in the current clinical setting. Med. Intensiva, 2012, 36(3), 213-219.
9. Ikonomidou, C.; Turski, L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol., 2002, 1(6), 383-386. (Pubitemid 37159164)
10. Sullivan, P. G.; Keller, J. N.; Mattson, M. P.; Scheff, S. W. Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. J. Neurotrauma, 1998, 15(10), 789-798. (Pubitemid 28487993)
11. Weng, G.; Bhalla, U. S.; Iyengar, R. Complexity in biological signaling systems. Science, 1999, 284(5411), 92-96. (Pubitemid 29282052)
12. Stamler, J. S.; Simon, D. I.; Jaraki, O.; Osborne, J. A.; Francis, S.; Mullins, M.; Singel, D.; Loscalzo, J. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc. Natl. Acad. Sci. USA, 1992, 89(17), 8087-8091.
13. Silver, I.; Erecinska, M. Oxygen and ion concentrations in normoxic and hypoxic brain cells. Adv. Exp. Med. Biol., 1998, 454, 7-16. (Pubitemid 29005509)
14. Kann, O.; Kovacs, R. Mitochondria and neuronal activity. Am. J. Physiol. Cell Physiol., 2007, 292(2), C641-C657.
15. Waldbaum, S.; Liang, L. P.; Patel, M. Persistent impairment of mitochondrial and tissue redox status during lithium-pilocarpineinduced epileptogenesis. J. Neurochem., 2010, 115(5), 1172-1182.
16. Lehninger, D. L.; Cox, M. M. Principles of Biochemistry. 6th ed.; W. H. Freeman: New York, 2013.
17. Emerit, J.; Edeas, M.; Bricaire, F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother., 2004, 58(1), 39-46. (Pubitemid 38117047)
18. Chen, Y.; Swanson, R. A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab., 2003, 23(2), 137-149. (Pubitemid 36188452)
19. Delbarre, G.; Delbarre, B.; Calinon, F.; Ferger, A. Accumulation of amino acids and hydroxyl free radicals in brain and retina of gerbil after transient ischemia. J. Ocul. Pharmacol., 1991, 7(2), 147-155.
20. Xiong, Z. G.; Zhu, X. M.; Chu, X. P.; Minami, M.; Hey, J.; Wei, W. L.; MacDonald, J. F.; Wemmie, J. A.; Price, M. P.; Welsh, M. J.; Simon, R. P. Neuroprotection in ischemia: blocking calciumpermeable acid-sensing ion channels. Cell, 2004, 118(6), 687-698. (Pubitemid 39221729)
21. Ascenzi, P.; Bocedi, A.; Visca, P.; Altruda, F.; Tolosano, E.; Beringhelli, T.; Fasano, M. Hemoglobin and heme scavenging. IUBMB Life, 2005, 57(11), 749-759. (Pubitemid 41781830)
22. Marzatico, F.; Gaetani, P.; Cafe, C.; Spanu, G.; Rodriguez y Baena, R. Antioxidant enzymatic activities after experimental subarachnoid hemorrhage in rats. Acta Neurol. Scand., 1993, 87(1), 62-66. (Pubitemid 23023671)
23. Arai, T.; Takeyama, N.; Tanaka, T. Glutathione monoethyl ester and inhibition of the oxyhemoglobin-induced increase in cytosolic calcium in cultured smooth-muscle cells. J. Neurosurg., 1999, 90(3), 527-532. (Pubitemid 29104602)
24. Asano, T. Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions. Crit. Rev. Neurosurg., 1999, 9(5), 303-318.
25. Marzatico, F.; Gaetani, P.; Silvani, V.; Lombardi, D.; Sinforiani, E.; Rodriguez y Baena, R. Experimental isobaric subarachnoid hemorrhage: regional mitochondrial function during the acute and late phase. Surg. Neurol., 1990, 34(5), 294-300. (Pubitemid 20363176)
26. Solaroglu, I.; Okutan, O.; Kaptanoglu, E.; Beskonakli, E.; Kilinc, K. Increased xanthine oxidase activity after traumatic brain injury in rats. J. Clin. Neurosci., 2005, 12(3), 273-275. (Pubitemid 40585725)
27. Ansari, M. A.; Joshi, G.; Huang, Q.; Opii, W. O.; Abdul, H. M.; Sultana, R.; Butterfield, D. A. In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid betapeptide and other oxidative stressors: relevance to Alzheimer's disease and other oxidative stress-related neurodegenerative disorders. Free Radic. Biol. Med., 2006, 41(11), 1694-1703. (Pubitemid 44634240)
28. Dringen, R.; Pawlowski, P. G.; Hirrlinger, J. Peroxide detoxification by brain cells. J. Neurosci. Res., 2005, 79(1-2), 157-165. (Pubitemid 40116430)
29. Choe, H.; Hansen, J. M.; Harris, C. Spatial and temporal ontogenies of glutathione peroxidase and glutathione disulfide reductase during development of the prenatal rat. J. Biochem. Mol. Toxicol., 2001, 15(4), 197-206. (Pubitemid 32734326)
30. Ansari, M. A.; Roberts, K. N.; Scheff, S. W. Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic. Biol. Med., 2008, 45(4), 443-452.
31. Sorce, S.; Krause, K. H. NOX enzymes in the central nervous system: from signaling to disease. Antioxid. Redox. Signal., 2009, 11(10), 2481-2504.
32. Chen, H.; Song, Y. S.; Chan, P. H. Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J. Cereb. Blood Flow Metab., 2009, 29(7), 1262-1272.
33. Zhang, Q. G.; Laird, M. D.; Han, D.; Nguyen, K.; Scott, E.; Dong, Y.; Dhandapani, K. M.; Brann, D. W. Critical role of NADPH oxidase in neuronal oxidative damage and microglia activation following traumatic brain injury. PLoS One, 2012, 7(4), e34504.
34. Choi, B. Y.; Jang, B. G.; Kim, J. H.; Lee, B. E.; Sohn, M.; Song, H. K.; Suh, S. W. Prevention of traumatic brain injury-induced neuronal death by inhibition of NADPH oxidase activation. Brain Res., 2012, 1481, 49-58.
35. Harrison, R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic. Biol. Med., 2002, 33(6), 774-797. (Pubitemid 35232313)
36. Holscher, C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends. Neurosci., 1997, 20(7), 298-303. (Pubitemid 27348739)
37. Iadecola, C.; Zhang, F.; Casey, R.; Nagayama, M.; Ross, M. E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci., 1997, 17(23), 9157-9164. (Pubitemid 27498443)
38. Lipton, S. A.; Choi, Y. B.; Pan, Z. H.; Lei, S. Z.; Chen, H. S.; Sucher, N. J.; Loscalzo, J.; Singel, D. J.; Stamler, J. S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature, 1993, 364(6438), 626-632. (Pubitemid 23274719)
39. Huang, Z.; Huang, P. L.; Panahian, N.; Dalkara, T.; Fishman, M. C.; Moskowitz, M. A., Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science, 1994, 265(5180), 1883-1885. (Pubitemid 24324247)
40. Clark, R. S.; Kochanek, P. M.; Schwarz, M. A.; Schiding, J. K.; Turner, D. S.; Chen, M.; Carlos, T. M.; Watkins, S. C. Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats. Pediatr. Res., 1996, 39(5), 784-790. (Pubitemid 26130017)
41. Iadecola, C.; Zhang, F.; Xu, X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol., 1995, 268(1 Pt 2), R286-R292.
42. Sinz, E. H.; Kochanek, P. M.; Dixon, C. E.; Clark, R. S.; Carcillo, J. A.; Schiding, J. K.; Chen, M.; Wisniewski, S. R.; Carlos, T. M.; Williams, D.; De Kosky, S. T.; Watkins, S. C.; Marion, D. W.; Billiar, T. R. Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J. Clin. Invest., 1999, 104(5), 647-656.
43. Miao, L.; St Clair, D. K. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med., 2009, 47(4), 344-356.
44. Ellerby, L. M.; Cabelli, D. E.; Graden, J. A.; Valentine, J. S. Copperzinc superoxide dismutase: why not pH dependent?. J. Am. Chem. Soc., 1996, 118, 6556-6561. (Pubitemid 26248149)
45. Aguiar, C. C.; Almeida, A. B.; Araujo, P. V.; de Abreu, R. N.; Chaves, E. M.; do Vale, O. C.; Macedo, D. S.; Woods, D. J.; Fonteles, M. M.; Vasconcelos, S. M. Oxidative stress and epilepsy: literature review. Oxid. Med. Cell. Longev., 2012, 2012, 795259.
46. Bayir, H.; Kagan, V. E.; Clark, R. S.; Janesko-Feldman, K.; Rafikov, R.; Huang, Z.; Zhang, X.; Vagni, V.; Billiar, T. R.; Kochanek, P. M. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J. Neurochem., 2007, 101(1), 168-181. (Pubitemid 46426473)
47. Noshita, N.; Sugawara, T.; Lewen, A.; Hayashi, T.; Chan, P. H. Copper-zinc superoxide dismutase affects Akt activation after transient focal cerebral ischemia in mice. Stroke, 2003, 34(6), 1513-1518. (Pubitemid 36693527)
48. Yunoki, M.; Kawauchi, M.; Ukita, N.; Noguchi, Y.; Nishio, S.; Ono, Y.; Asari, S.; Ohmoto, T.; Asanuma, M.; Ogawa, N. Effects of lecithinized superoxide dismutase on traumatic brain injury in rats. J. Neurotrauma, 1997, 14(10), 739-746. (Pubitemid 27479414)
49. Endo, H.; Nito, C.; Kamada, H.; Yu, F.; Chan, P. H. Reduction in oxidative stress by superoxide dismutase overexpression attenuates acute brain injury after subarachnoid hemorrhage via activation of Akt/glycogen synthase kinase-3beta survival signaling. J. Cereb. Blood Flow Metab., 2007, 27(5), 975-982. (Pubitemid 46659025)
50. Young, B.; Runge, J. W.; Waxman, K. S.; Harrington, T.; Wilberger, J.; Muizelaar, J. P.; Boddy, A.; Kupiec, J. W. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA, 1996, 276(7), 538-543. (Pubitemid 26272298)
51. Smith, S. L.; Andrus, P. K.; Zhang, J. R.; Hall, E. D. Direct measurement of hydroxyl radicals, lipid peroxidation, and bloodbrain barrier disruption following unilateral cortical impact head injury in the rat. J. Neurotrauma, 1994, 11(4), 393-404. (Pubitemid 24304691)
52. Hall, E. D.; Andrus, P. K.; Yonkers, P. A. Brain hydroxyl radical generation in acute experimental head injury. J. Neurochem., 1993, 60(2), 588-594. (Pubitemid 23030955)
53. Gandhi, S.; Abramov, A. Y. Mechanism of oxidative stress in neurodegeneration. Oxid. Med. Cell. Longev., 2012, 2012, 428010.
54. De Kosky, S. T.; Taffe, K. M.; Abrahamson, E. E.; Dixon, C. E.; Kochanek, P. M.; Ikonomovic, M. D. Time course analysis of hippocampal nerve growth factor and antioxidant enzyme activity following lateral controlled cortical impact brain injury in the rat. J. Neurotrauma, 2004, 21(5), 491-500. (Pubitemid 38656747)
55. Goss, J. R.; Taffe, K. M.; Kochanek, P. M.; De Kosky, S. T. The antioxidant enzymes glutathione peroxidase and catalase increase following traumatic brain injury in the rat. Exp. Neurol., 1997, 146(1), 291-294. (Pubitemid 27319745)
56. Kerman, M.; Kanter, M.; Coskun, K. K.; Erboga, M.; Gurel, A. Neuroprotective effects of caffeic acid phenethyl ester on experimental traumatic brain injury in rats. J. Mol. Histol., 2012, 43(1), 49-57.
57. Arthur, J. R. The glutathione peroxidases. Cell Mol. Life Sci., 2000, 57(13-14), 1825-1835. (Pubitemid 32102578)
58. Valko, M.; Rhodes, C. J.; Moncol, J.; Izakovic, M.; Mazur, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact., 2006, 160(1), 1-40. (Pubitemid 43227479)
59. Limon-Pacheco, J.; Gonsebatt, M. E. The role of antioxidants and antioxidant-related enzymes in protective responses to environmentally induced oxidative stress. Mutat. Res., 2009, 674(1-2), 137-147.
60. Kuo, J. R.; Lo, C. J.; Chang, C. P.; Lin, M. T.; Chio, C. C. Attenuation of brain nitrostative and oxidative damage by brain cooling during experimental traumatic brain injury. J. Biomed. Biotechnol., 2011, 2011, 145214.
61. Beyaert, R.; Fiers, W. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett., 1994, 340(1-2), 9-16.
62. Kihara, T.; Sakata, S.; Ikeda, M. Direct detection of ascorbyl radical in experimental brain injury: microdialysis and an electron spin resonance spectroscopic study. J. Neurochem., 1995, 65(1), 282-286.
63. Tyurin, V. A.; Tyurina, Y. Y.; Borisenko, G. G.; Sokolova, T. V.; Ritov, V. B.; Quinn, P. J.; Rose, M.; Kochanek, P.; Graham, S. H.; Kagan, V. E. Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J. Neurochem., 2000, 75(5), 2178-2189.
64. Polidori, M. C.; Mecocci, P.; Frei, B. Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke, 2001, 32(4), 898-902. (Pubitemid 32285157)
65. Bayir, H.; Kagan, V. E.; Tyurina, Y. Y.; Tyurin, V.; Ruppel, R. A.; Adelson, P. D.; Graham, S. H.; Janesko, K.; Clark, R. S.; Kochanek, P. M. Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr. Res., 2002, 51(5), 571-578. (Pubitemid 34453572)
66. Berger, M. M.; Soguel, L.; Shenkin, A.; Revelly, J. P.; Pinget, C.; Baines, M.; Chiolero, R. L. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit. Care, 2008, 12(4), R101.
67. Razmkon, A.; Sadidi, A.; Sherafat-Kazemzadeh, E.; Mehrafshan, A.; Jamali, M.; Malekpour, B.; Saghafinia, M. Administration of vitamin C and vitamin E in severe head injury: a randomized double-blind controlled trial. Clin. Neurosurg., 2011, 58, 133-137.
68. Hans, P.; Franssen, C.; Pincemail, J.; Bertrand, Y.; Hannique, G.; Damas, P.; Lamy, M. Plasma myeloperoxidase and vitamin E levels in head injury: preliminary results related to outcome. J. Neurosurg. Anesthesiol., 1992, 4(1), 26-30.
69. Inci, S.; Ozcan, O. E.; Kilinc, K. Time-level relationship for lipid peroxidation and the protective effect of alpha-tocopherol in experimental mild and severe brain injury. Neurosurgery, 1998, 43(2), 330-335; discussion 335-336.
70. Aiguo, W.; Zhe, Y.; Gomez-Pinilla, F. Vitamin E protects against oxidative damage and learning disability after mild traumatic brain injury in rats. Neurorehabil. Neural. Repair., 2010, 24(3), 290-298.
71. Yang, J.; Han, Y.; Ye, W.; Liu, F.; Zhuang, K.; Wu, G. Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury. J. Surg. Res., 2013, 182(2), e69-e77.
72. Tan, D. X.; Manchester, L. C.; Terron, M. P.; Flores, L. J.; Reiter, R. J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. Pineal. Res., 2007, 42(1), 28-42. (Pubitemid 44924323)
73. Bonnefont-Rousselot, D.; Collin, F.; Jore, D.; Gardes-Albert, M. Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J. Pineal. Res., 2011, 50(3), 328-335.
74. Galano, A.; Tan, D. X.; Reiter, R. J. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J. Pineal. Res., 2011, 51(1), 1-16.
75. Beni, S. M.; Kohen, R.; Reiter, R. J.; Tan, D. X.; Shohami, E. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated latephase activation of NF-kappaB and AP-1. FASEB J., 2004, 18(1), 149-151.
76. Maldonado, M. D.; Murillo-Cabezas, F.; Terron, M. P.; Flores, L. J.; Tan, D. X.; Manchester, L. C.; Reiter, R. J. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J. Pineal. Res., 2007, 42(1), 1-11. (Pubitemid 44924321)
77. Ayer, R. E.; Sugawara, T.; Chen, W.; Tong, W.; Zhang, J. H. Melatonin decreases mortality following severe subarachnoid hemorrhage. J. Pineal. Res., 2008, 44(2), 197-204. (Pubitemid 351252923)
78. Mesenge, C.; Margaill, I.; Verrecchia, C.; Allix, M.; Boulu, R. G.; Plotkine, M. Protective effect of melatonin in a model of traumatic brain injury in mice. J. Pineal. Res., 1998, 25(1), 41-46. (Pubitemid 28319915)
79. Sarrafzadeh, A. S.; Thomale, U. W.; Kroppenstedt, S. N.; Unterberg, A. W. Neuroprotective effect of melatonin on cortical impact injury in the rat. Acta Neurochir. (Wien.), 2000, 142(11), 1293-1299. (Pubitemid 32010354)
80. Dehghan, F.; Khaksari Hadad, M.; Asadikram, G.; Najafipour, H.; Shahrokhi, N. Effect of melatonin on intracranial pressure and brain edema following traumatic brain injury: role of oxidative stresses. Arch. Med. Res., 2013, 44(4), 251-258.
81. Roof, R. L.; Duvdevani, R.; Stein, D. G. Progesterone treatment attenuates brain edema following contusion injury in male and female rats. Restor. Neurol. Neurosci., 1992, 4(6), 425-427. (Pubitemid 23001029)
82. Roof, R. L.; Duvdevani, R.; Braswell, L.; Stein, D. G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol., 1994, 129(1), 64-69. (Pubitemid 24344157)
83. Roof, R. L.; Duvdevani, R.; Heyburn, J. W.; Stein, D. G. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp. Neurol., 1996, 138(2), 246-251. (Pubitemid 26132712)
84. Roof, R. L.; Hoffman, S. W.; Stein, D. G. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol. Chem. Neuropathol., 1997, 31(1), 1-11. (Pubitemid 27328632)
85. Xiao, G. M.; Wei, J.; Wu, Z. H.; Wang, W. M.; Jiang, Q. Z.; Cheng, J.; Lu, F.; Wu, J. Y.; Xu, H. S.; Fang, R. Clinical study on the therapeutic effects and mechanism of progesterone in the treatment for acute severe head injury. Zhonghua Wai Ke Za Zhi, 2007, 45(2), 106-108.
86. Wright, D. W.; Kellermann, A. L.; Hertzberg, V. S.; Clark, P. L.; Frankel, M.; Goldstein, F. C.; Salomone, J. P.; Dent, L. L.; Harris, O. A.; Ander, D. S.; Lowery, D. W.; Patel, M. M.; Denson, D. D.; Gordon, A. B.; Wald, M. M.; Gupta, S.; Hoffman, S. W.; Stein, D. G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med., 2007, 49(4), 391-402, 402.e1-e2.
87. Aminmansour, B.; Nikbakht, H.; Ghorbani, A.; Rezvani, M.; Rahmani, P.; Torkashvand, M.; Nourian, M.; Moradi, M. Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: A randomized clinical trial with placebo group. Adv. Biomed. Res., 2012, 1, 58.
88. Peters, T., Jr. Serum albumin. Adv. Protein Chem., 1985, 37, 161-245.
89. Carter, D. C.; Ho, J. X. Structure of serum albumin. Adv. Protein Chem., 1994, 45, 153-203. (Pubitemid 24139888)
90. Oettl, K.; Stauber, R. E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol., 2007, 151(5), 580-590. (Pubitemid 47016287)
91. Roche, M.; Rondeau, P.; Singh, N. R.; Tarnus, E.; Bourdon, E. The antioxidant properties of serum albumin. FEBS Lett., 2008, 582(13), 1783-1787.
92. Finfer, S.; Bellomo, R.; Boyce, N.; French, J.; Myburgh, J.; Norton, R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N. Engl. J. Med., 2004, 350(22), 2247-2256. (Pubitemid 38669207)
93. Myburgh, J.; Cooper, D. J.; Finfer, S.; Bellomo, R.; Norton, R.; Bishop, N.; Kai Lo, S.; Vallance, S. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N. Engl. J. Med., 2007, 357(9), 874-884. (Pubitemid 47347321)
94. Squadrito, G. L.; Cueto, R.; Splenser, A. E.; Valavanidis, A.; Zhang, H.; Uppu, R. M.; Pryor, W. A., Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch. Biochem. Biophys., 2000, 376(2), 333-337. (Pubitemid 30210881)
95. Tayag, E. C.; Nair, S. N.; Wahhab, S.; Katsetos, C. D.; Lighthall, J. W.; Lehmann, J. C., Cerebral uric acid increases following experimental traumatic brain injury in rat. Brain Res., 1996, 733(2), 287-291. (Pubitemid 26308607)
96. Yu, Z. F.; Bruce-Keller, A. J.; Goodman, Y.; Mattson, M. P. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J. Neurosci. Res., 1998, 53(5), 613-625. (Pubitemid 28380802)
97. Haberman, F.; Tang, S. C.; Arumugam, T. V.; Hyun, D. H.; Yu, Q. S.; Cutler, R. G.; Guo, Z.; Holloway, H. W.; Greig, N. H.; Mattson, M. P. Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice. Neuromolecular Med., 2007, 9(4), 315-323. (Pubitemid 350242634)
98. Warner, D. S.; Sheng, H.; Batinic-Haberle, I. Oxidants, antioxidants and the ischemic brain. J. Exp. Biol., 2004, 207(Pt 18), 3221-3231. (Pubitemid 39275296)
99. Cakir, O.; Erdem, K.; Oruc, A.; Kilinc, N.; Eren, N. Neuroprotective effect of N-acetylcysteine and hypothermia on the spinal cord ischemia-reperfusion injury. Cardiovasc. Surg., 2003, 11(5), 375-379. (Pubitemid 37076009)
100. Cuzzocrea, S.; Mazzon, E.; Costantino, G.; Serraino, I.; De Sarro, A.; Caputi, A. P. Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc. Res., 2000, 47(3), 537-548. (Pubitemid 30646075)
101. Sekhon, B.; Sekhon, C.; Khan, M.; Patel, S. J.; Singh, I.; Singh, A. K. N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res., 2003, 971(1), 1-8. (Pubitemid 36412058)
102. Khan, M.; Sekhon, B.; Jatana, M.; Giri, S.; Gilg, A. G.; Sekhon, C.; Singh, I.; Singh, A. K. Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J. Neurosci. Res., 2004, 76(4), 519-527. (Pubitemid 38580467)
103. Hoffer, M. E.; Balaban, C.; Slade, M. D.; Tsao, J. W.; Hoffer, B. Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study. PLoS One, 2013, 8(1), e54163.
104. Feng, Y.; Le Blanc, M. H.; Le Blanc, E. B.; Parker, C. C.; Fratkin, J. D.; Qian, X. B.; Patel, D. M.; Huang, M.; Smith, E. E.; Vig, P. J. Desmethyl tirilazad improves neurologic function after hypoxic ischemic brain injury in piglets. Crit. Care Med., 2000, 28(5), 1431-1438. (Pubitemid 30324519)
105. Chen, Z.; Gao, C.; Hua, Y.; Keep, R. F.; Muraszko, K.; Xi, G. Role of iron in brain injury after intraventricular hemorrhage. Stroke, 2011, 42(2), 465-470.
106. Xing, Y.; Hua, Y.; Keep, R. F.; Xi, G. Effects of deferoxamine on brain injury after transient focal cerebral ischemia in rats with hyperglycemia. Brain Res., 2009, 1291, 113-321.
107. Nakamura, T.; Keep, R. F.; Hua, Y.; Schallert, T.; Hoff, J. T.; Xi, G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J. Neurosurg., 2004, 100(4), 672-678. (Pubitemid 38372849)
108. Marshall, L. F.; Maas, A. I.; Marshall, S. B.; Bricolo, A.; Fearnside, M.; Iannotti, F.; Klauber, M. R.; Lagarrigue, J.; Lobato, R.; Persson, L.; Pickard, J. D.; Piek, J.; Servadei, F.; Wellis, G. N.; Morris, G. F.; Means, E. D.; Musch, B. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. J. Neurosurg., 1998, 89(4), 519-525. (Pubitemid 28440918)
109. Maas, A. I.; Murray, G.; Henney, H., 3rd; Kassem, N.; Legrand, V.; Mangelus, M.; Muizelaar, J. P.; Stocchetti, N.; Knoller, N. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol., 2006, 5(1), 38-45. (Pubitemid 41790694)
110. Durmaz, R.; Ozden, H.; Kanbak, G.; Aral, E.; Arslan, O. C.; Kartkaya, K.; Uzuner, K. The protective effect of dexanabinol (HU-211) on nitric oxide and cysteine protease-mediated neuronal death in focal cerebral ischemia. Neurochem. Res., 2008, 33(9), 1683-1691.
111. A multicenter trial of the efficacy of nimodipine on outcome after severe head injury. The European Study Group on Nimodipine in Severe Head Injury. J. Neurosurg., 1994, 80(5), 797-804.
112. Aslan, A.; Gurelik, M.; Cemek, M.; Buyukokuroglu, M.; Goksel, H. M.; Eser, O. Nimodipine can diminish oxidative stress in patients with severe head trauma. J. Neurosurg. Sci., 2012, 56(3), 247-253.
113. Liberman, J. N.; Stewart, W. F.; Wesnes, K.; Troncoso, J. Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury. Neurology, 2002, 58(7), 1038-1044. (Pubitemid 34298542)
114. Crawford, F. C.; Vanderploeg, R. D.; Freeman, M. J.; Singh, S.; Waisman, M.; Michaels, L.; Abdullah, L.; Warden, D.; Lipsky, R.; Salazar, A.; Mullan, M. J. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology, 2002, 58(7), 1115-1118. (Pubitemid 34298559)
115. Sundstrom, A.; Marklund, P.; Nilsson, L. G.; Cruts, M.; Adolfsson, R.; Van Broeckhoven, C.; Nyberg, L. APOE influences on neuropsychological function after mild head injury: within-person comparisons. Neurology, 2004, 62(11), 1963-1966. (Pubitemid 38738204)
116. Leone, S.; Noera, G.; Bertolini, A. Melanocortins as innovative drugs for ischemic diseases and neurodegenerative disorders: established data and perspectives. Curr. Med. Chem., 2013, 20(6), 735-750.